Lei You

9.2k total citations · 5 hit papers
168 papers, 6.5k citations indexed

About

Lei You is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Lei You has authored 168 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Oncology, 92 papers in Molecular Biology and 58 papers in Cancer Research. Recurrent topics in Lei You's work include Pancreatic and Hepatic Oncology Research (88 papers), Epigenetics and DNA Methylation (30 papers) and Cancer Genomics and Diagnostics (20 papers). Lei You is often cited by papers focused on Pancreatic and Hepatic Oncology Research (88 papers), Epigenetics and DNA Methylation (30 papers) and Cancer Genomics and Diagnostics (20 papers). Lei You collaborates with scholars based in China, United Kingdom and Australia. Lei You's co-authors include Yupei Zhao, Taiping Zhang, Gang Yang, Mengyu Feng, Jinshou Yang, Lianfang Zheng, Bo Ren, Jiangdong Qiu, Li Zhou and Zhe Cao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Lei You

164 papers receiving 6.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor microenvironment participates in metastasis of pancreatic cancer

2018 421 citations Ming Cui, Gang Yang et al. profile →
Targeting hypoxic tumor microenvironment in pancreatic cancer

2021 297 citations Jinxin Tao, Gang Yang et al. profile →
Metabolism of pancreatic cancer: paving the way to better anticancer strategies

2020 283 citations Gang Yang, Jinshou Yang et al. profile →
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis

2021 260 citations Lei You, Taiping Zhang et al. Cancer Letters profile →
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review

2021 214 citations Jinshou Yang, Ruiyuan Xu et al. Cancer Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lei You China	44	3.3k	2.6k	2.5k	798	795	168	6.5k
Bolin Liu United States	46	4.5k 1.4×	3.1k 1.2×	1.6k 0.6×	345 0.4×	492 0.6×	157	7.3k
Xin‐Rong Yang China	48	3.3k 1.0×	3.5k 1.3×	2.9k 1.2×	1.2k 1.6×	1.0k 1.3×	181	9.3k
Guohong Hu China	41	4.3k 1.3×	2.2k 0.8×	2.9k 1.2×	746 0.9×	275 0.3×	107	7.2k
Rui Manuel Reis Brazil	49	4.9k 1.5×	2.1k 0.8×	2.9k 1.2×	592 0.7×	647 0.8×	382	9.3k
En‐Min Li China	42	4.0k 1.2×	1.1k 0.4×	1.7k 0.7×	590 0.7×	790 1.0×	293	6.2k
Wenxin Qin China	44	5.3k 1.6×	1.4k 0.5×	3.3k 1.3×	837 1.0×	449 0.6×	137	7.7k
Lutao Du China	48	5.2k 1.6×	960 0.4×	3.8k 1.5×	510 0.6×	601 0.8×	136	7.0k
Zhaojian Gong China	38	3.7k 1.1×	1.4k 0.5×	3.1k 1.3×	955 1.2×	635 0.8×	109	6.2k
Wangjun Liao China	50	4.7k 1.4×	2.2k 0.8×	3.3k 1.3×	1.1k 1.4×	955 1.2×	222	8.8k
Yifan Wang China	37	3.0k 0.9×	2.4k 0.9×	1.1k 0.4×	1.1k 1.4×	604 0.8×	194	7.1k

Countries citing papers authored by Lei You

Since Specialization

Citations

This map shows the geographic impact of Lei You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei You more than expected).

Fields of papers citing papers by Lei You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei You. The network helps show where Lei You may publish in the future.

Co-authorship network of co-authors of Lei You

This figure shows the co-authorship network connecting the top 25 collaborators of Lei You. A scholar is included among the top collaborators of Lei You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei You. Lei You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Wenbo, Guangyu Chen, Jinxin Tao, et al.. (2025). Decipher the single-cell level responses to chemotherapy in pancreatic ductal adenocarcinoma by a cross-time context graph model. Cancer Letters. 626. 217751–217751.

You, Lei, Ming Gao, Christian Damgaard, et al.. (2025). Elevated temperature magnifies the toxicity of imidacloprid in the collembolan, Folsomia candida. Environmental Pollution. 374. 126260–126260. 2 indexed citations

Cui, Ming, et al.. (2025). Sialic Acids: Sweet modulators fueling cancer cells and domesticating the tumor microenvironment. Cancer Letters. 626. 217773–217773. 3 indexed citations

Bai, Yulin, et al.. (2025). Integrated analysis of lncRNA-miRNA-mRNA regulatory network revealing molecular mechanisms of immune response and ion transport in Eriocheir sinensis under alkalinity stress. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 297. 110262–110262. 1 indexed citations

Yang, Jinshou, Yuan Fang, Xing Wang, et al.. (2025). Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies. Cell Death Discovery. 11(1). 84–84. 7 indexed citations

Ren, Bo, et al.. (2024). Construction of a novel model based on PVT1-MYC duet-related genes for predicting survival and characterization of the tumor microenvironment in pancreatic cancer. Frontiers in Immunology. 15. 2 indexed citations

Ren, Bo, et al.. (2024). Microbiota-metabolism-epigenetics-immunity axis in cancer. Frontiers in Immunology. 15. 1449912–1449912. 3 indexed citations

Yang, Jinshou, Bo Ren, Jie Ren, et al.. (2023). Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. Journal of Experimental & Clinical Cancer Research. 42(1). 155–155. 20 indexed citations

Xiong, Kai, Shunmeng Zhang, Yingxu Wang, et al.. (2022). A comparative study the structural, mechanical, and electronic properties of medium-entropy MAX phase (TiZrHf)2SC with Ti2SC, Zr2SC, Hf2SC via first-principles. Journal of Materials Research and Technology. 19. 2717–2729. 26 indexed citations

10.

Yang, Gang, Zhe Cao, Wenbo Guo, et al.. (2021). Integrative Genomic Analysis of Gemcitabine Resistance in Pancreatic Cancer by Patient-derived Xenograft Models. Clinical Cancer Research. 27(12). 3383–3396. 59 indexed citations

11.

Yang, Jinshou, Ruiyuan Xu, Chengcheng Wang, et al.. (2021). Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Communications. 41(12). 1257–1274. 214 indexed citations breakdown →

12.

Chen, Yuan, Ruiyuan Xu, Rexiati Ruze, et al.. (2021). Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer. Cancer Cell International. 21(1). 291–291. 8 indexed citations

13.

Yang, Gang, Guangbing Xiong, Mengyu Feng, et al.. (2020). OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2. Molecular Cancer Research. 18(5). 685–697. 47 indexed citations

14.

Chen, Yuan, Bo Ren, Jinshou Yang, et al.. (2020). The role of histone methylation in the development of digestive cancers: a potential direction for cancer management. Signal Transduction and Targeted Therapy. 5(1). 143–143. 95 indexed citations

15.

Du, Yongxing, Ziwen Liu, Lei You, et al.. (2017). Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14. Cancer Research. 77(10). 2661–2673. 37 indexed citations

16.

Wang, Xianze, Xiafei Hong, Haiyu Pang, et al.. (2016). Selecting optimal surgical procedures for intraductal papillary mucinous neoplasm (IPMN): An analysis based on the Surveillance, Epidemiology, and End Result registry database. European Journal of Surgical Oncology. 42(10). 1526–1532. 5 indexed citations

17.

Wang, Yuxuan, Changzheng Liu, Min Luo, et al.. (2015). Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer. Cancer Research. 75(7). 1332–1344. 55 indexed citations

18.

Guo, Junchao, Jian Li, Yu-pei Zhao, et al.. (2014). N-WASP in Pancreatic Ductal Adenocarcinoma: Associations with Perineural Invasion and Poor Prognosis. World Journal of Surgery. 38(8). 2126–2131. 18 indexed citations

19.

Zhao, Yupei, Taiping Zhang, Li Zhou, et al.. (2013). Alteration of the Intrinsic Apoptosis Pathway Is Involved in Notch-induced Chemoresistance to Gemcitabine in Pancreatic Cancer. Archives of Medical Research. 45(1). 15–20. 15 indexed citations

20.

Chen, Liyang, et al.. (2010). A multi-center study of Restylane for treatment of nasolabial folds in China. Chinese Medical Journal. 123(2). 173–177. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact